Fractyl Health Inc
NASDAQ:GUTS
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
L
|
Ligao Foods Co Ltd
SZSE:300973
|
CN |
|
Brenntag SE
XETRA:BNR
|
DE |
|
T
|
TANSH Global Food Group Co Ltd
HKEX:3666
|
CN |
Fractyl Health Inc
Total Current Assets
Fractyl Health Inc
Total Current Assets Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Total Current Assets | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
F
|
Fractyl Health Inc
NASDAQ:GUTS
|
Total Current Assets
$71.8m
|
CAGR 3-Years
-9%
|
CAGR 5-Years
60%
|
CAGR 10-Years
N/A
|
|
|
B
|
Baker Hughes Co
NASDAQ:BKR
|
Total Current Assets
$18.8B
|
CAGR 3-Years
9%
|
CAGR 5-Years
3%
|
CAGR 10-Years
7%
|
|
|
Schlumberger NV
NYSE:SLB
|
Total Current Assets
$19.5B
|
CAGR 3-Years
9%
|
CAGR 5-Years
9%
|
CAGR 10-Years
-3%
|
|
|
Halliburton Co
NYSE:HAL
|
Total Current Assets
$11.4B
|
CAGR 3-Years
1%
|
CAGR 5-Years
4%
|
CAGR 10-Years
-6%
|
|
|
Symbotic Inc
NASDAQ:SYM
|
Total Current Assets
$1.9B
|
CAGR 3-Years
46%
|
CAGR 5-Years
55%
|
CAGR 10-Years
N/A
|
|
|
R
|
Reddit Inc
NYSE:RDDT
|
Total Current Assets
$3.1B
|
CAGR 3-Years
28%
|
CAGR 5-Years
46%
|
CAGR 10-Years
N/A
|
|
Fractyl Health Inc
Glance View
Fractyl Health Inc is a US-based company operating in industry. The company is headquartered in Lexington, Massachusetts and currently employs 88 full-time employees. The company went IPO on 2024-02-02. Fractyl Health, Inc. is a metabolic therapeutics company. The firm is focused on approaches to the treatment of metabolic diseases, including type 2 diabetes (T2D) and obesity. The Revita DMR System (Revita), the Company’s lead product candidate, is an outpatient procedural therapy designed to durably modify duodenal dysfunction, a pathologic consequence of a high fat and high sugar diet, which can initiate T2D and obesity in humans. The Revita system is designed to enable durable and repeatable metabolic improvement via hydrothermal ablation of the dysfunctional duodenal mucosa to address duodenal pathology and consequent metabolic disease progression directly. The firm is involved in enrolling is pivotal Revitalize-1 study in patients with inadequately controlled T2D. The company is also developing Rejuva, a locally administered, adeno-associated virus (AAV), delivered pancreatic gene therapy (PGTx), platform. Rejuva is designed to enable long-term remission of T2D and obesity.
See Also
What is Fractyl Health Inc's Total Current Assets?
Total Current Assets
71.8m
USD
Based on the financial report for Dec 31, 2024, Fractyl Health Inc's Total Current Assets amounts to 71.8m USD.
What is Fractyl Health Inc's Total Current Assets growth rate?
Total Current Assets CAGR 5Y
60%
Over the last year, the Total Current Assets growth was 101%. The average annual Total Current Assets growth rates for Fractyl Health Inc have been -9% over the past three years , 60% over the past five years .
